| Description | Acetamide, N-[2-[(5-chloro-2 methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]-inhibits pro-matrix metalloproteinase activation and can be used to prevent, treat or ameliorate MMP9 and/or MMP13-mediated syndromes. |
| Target activity | TAOK2:1.1 µM |
| molecular weight | 394.9 |
| Molecular formula | C16H15ClN4O2S2 |
| CAS | 333746-76-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 50 mg/mL (126.61 mM) |
| References | 1. Piala AT, et al. Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening. Bioorg Med Chem Lett. 2016 ; 26(16):3923-3927. |